Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis

Area of Science:

• Immunogenetics
• Rheumatology
• Vascular Biology

Background:

• Takayasu arteritis is a large-vessel vasculitis linked to HLA-B*52:01, prompting its potential classification within MHC-I-opathies.
• The roles of ERAP1 and ERAP2, implicated in other MHC-I-opathies, are not well-defined in Takayasu arteritis.

Purpose of the Study:

• To investigate the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis.
• To determine if ERAP1/ERAP2 polymorphisms are associated with Takayasu arteritis.

Main Methods:

• Utilized large multi-ancestral Genome-Wide Association Study (GWAS) data.
• Performed genetic interaction analyses between ERAP1/ERAP2 polymorphisms and HLA-B*52:01.
• Conducted meta-analyses and stratified association tests based on HLA-B*52:01 status.

Main Results:

• No significant genetic interactions were found between ERAP1 or ERAP2 and HLA-B*52:01 in Takayasu arteritis.
• ERAP1/ERAP2 polymorphisms showed no significant association with Takayasu arteritis across various genetic models and stratifications.

Conclusions:

• The genetic profile of Takayasu arteritis appears distinct from other MHC-I-opathies.
• These findings support classifying Takayasu arteritis as a unique subtype of immune-mediated diseases.
• Further research and validation in larger patient cohorts are recommended.